title: Trials and tribulations of noninferiority: the ximelagatran experience.
authors.forename: Gregory W
authors.initials: GW
authors.lastname: Albers
authors.forename: Hans-Christoph
authors.initials: HC
authors.lastname: Diener
authors.forename: Lars
authors.initials: L
authors.lastname: Frison
authors.forename: Margaretha
authors.initials: M
authors.lastname: Grind
authors.forename: Jay
authors.initials: J
authors.lastname: Horrow
authors.forename: Mark
authors.initials: M
authors.lastname: Nevinson
authors.forename: S Bertil
authors.initials: SB
authors.lastname: Olsson
authors.forename: Stephen
authors.initials: S
authors.lastname: Partridge
authors.forename: Palle
authors.initials: P
authors.lastname: Petersen
authors.forename: Alec
authors.initials: A
authors.lastname: Vahanian
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D023381:Endpoint Determination; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran; D014859:Warfarin